WEIGHT LOSS DRUGS INSURANCE COVERAGE
New Mexico bill mandating health insurance coverage of FDA-approved weight loss medications to improve access, potentially increasing premiums while reducing patient costs.
New Mexico bill mandating health insurance coverage of FDA-approved weight loss medications to improve access, potentially increasing premiums while reducing patient costs.
SB 193 would require health insurance plans in New Mexico to cover FDA-approved weight loss medications (such as GLP-1 receptor agonists like semaglutide and tirzepatide). The bill mandates insurance coverage for these drugs when prescribed by a physician, potentially removing cost barriers that currently limit access to these medications for many New Mexicans.
Weight loss medications have emerged as effective treatments for obesity and related conditions like type 2 diabetes, but their high out-of-pocket costs ($900-$1,500+ monthly without insurance) make them inaccessible to many patients. Mandating insurance coverage could significantly expand access to these treatments while shifting costs from individuals to insurers and employers, with potential downstream effects on state healthcare spending and public health outcomes.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.